Normal
On 3 September 2018 Immutep Limited announced that it will commence cell line development and the associated manufacturing steps for IMP761, an immunosuppressive agonist antibody to LAG-3. Since then, volume has increased dramatically and the share price has moved from 3.5c to close at 4.5c today.As I mentioned in my last post in this thread, I don't really understand biotechs but there seems to be an air of confidence swirling around IMM at the moment. Worth a look perhaps for those who understand it a little better than I do.[ATTACH=full]89279[/ATTACH]
On 3 September 2018 Immutep Limited announced that it will commence cell line development and the associated manufacturing steps for IMP761, an immunosuppressive agonist antibody to LAG-3. Since then, volume has increased dramatically and the share price has moved from 3.5c to close at 4.5c today.
As I mentioned in my last post in this thread, I don't really understand biotechs but there seems to be an air of confidence swirling around IMM at the moment. Worth a look perhaps for those who understand it a little better than I do.
[ATTACH=full]89279[/ATTACH]
Hello and welcome to Aussie Stock Forums!
To gain full access you must register. Registration is free and takes only a few seconds to complete.
Already a member? Log in here.
